Advertisement

Topics

Atomwise Inc. Company Profile

12:49 EST 13th December 2018 | BioPortfolio

Atomwise uses artificial intelligence to help discover new medicines and agricultural compounds. Its groundbreaking AtomNet technology reasons like a human chemist, using powerful deep learning algorithms and supercomputers to analyze millions of potential molecules each day. Atomwise has launched more than 50 discovery projects in partnership with the world’s top research companies and universities. Now, through its many partnering programs and robust venture funding, Atomwise is actively seeking new collaborators to address the global health challenges of our time using the power of artificial intelligence.


News Articles [8 Associated News Articles listed on BioPortfolio]

Atomwise Enters Evaluation Agreement With Pfizer

NEW YORK CITY (dpa-AFX) - Atomwise Inc. announced an evaluation agreement with Pfizer Inc. (PFE). Pfizer will evaluate Atomwise's platform to identify potential drug candidates for up to three tar...

Pfizer to evaluate Atomwise’s platform to identify drug candidates for three target proteins

Pfizer will evaluate Atomwise’s platform to identify potential drug candidates for up to three target proteins selected by Pfizer. In the agreement, Pfizer will pay a technology access The post Pfi...

Atomwise Awards Support Academic Researchers

Atomwise, Inc., a leader in using artificial intelligence (AI) for drug screening and design, is now accepting applications for their 2018 Artificial Intelligence Molecular Screen (AIMS) awards. The a...

Atomwise Enters Into an Evaluation Agreement with Pfizer

Atomwise Inc., a leader in Artificial Intelligence (AI) for drug discovery and design, has entered into an evaluation agreement with Pfizer Inc. (NYSE: PFE). Pfizer will evaluate ...

Atomwise identifying small molecules for Pfizer

Atomwise Expands its Groundbreaking Artificial Intelligence Screening Program to Support Academic Projects Worldwide

The post Atomwise Expands its Groundbreaking Artificial Intelligence Screening Program to Support Academic Projects Worldwide appeared first on SynBioBeta.

Pfizer News: Alopecia Drugs Show Promise, and Company Inks Deal with Atomwise http://dlvr.it/QkTW0S pic.twitter.com/sPefia694a

Pfizer News: Alopecia Drugs Show Promise, and Company Inks Deal with Atomwise http://dlvr.it/QkTW0S  pic.twitter.com/sPefia694a

Pfizer News: Alopecia Drugs Show Promise, and Company Inks Deal with Atomwise

Pfizer announced results from its Phase IIa clinical trial of PF-06651600 and PF-06700841 in alopecia areata (AA).

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Atomwise Inc.

Atomwise uses artificial intelligence to help discover new medicines and agricultural compounds. Its groundbreaking AtomNet technology reasons like a human chemist, using powerful...

More Information about "Atomwise Inc." on BioPortfolio

We have published hundreds of Atomwise Inc. news stories on BioPortfolio along with dozens of Atomwise Inc. Clinical Trials and PubMed Articles about Atomwise Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Atomwise Inc. Companies in our database. You can also find out about relevant Atomwise Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record